DOCSLIB.ORG

Regulation of OSR1 and the Sodium, Potassium, Two Chloride Cotransporter by Convergent Signals

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Regulation of OSR1 and the Sodium, Potassium, Two Chloride Cotransporter by Convergent Signals Regulation of OSR1 and the sodium, potassium, two chloride cotransporter by convergent signals Samarpita Senguptaa, Andrés Lorente-Rodrígueza, Svetlana Earnesta, Steve Stippeca, Xiaofeng Guob, David C. Trudgianb, Hamid Mirzaeib, and Melanie H. Cobba,1 Departments of aPharmacology and bBiochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9041 Contributed by Melanie H. Cobb, October 3, 2013 (sent for review October 6, 2012) The Ste20 family protein kinases oxidative stress-responsive 1 (ENaC) (23, 24). SGKs and the related Akt enzymes are acti- (OSR1) and the STE20/SPS1-related proline-, alanine-rich kinase vated by phosphorylation on multiple sites, most prominently a directly regulate the solute carrier 12 family of cation-chloride residue in the activation loop by the phosphoinositide-dependent cotransporters and thereby modulate a range of processes includ- protein kinase and on a second site in a C-terminal hydrophobic ing cell volume homeostasis, blood pressure, hearing, and kidney motif (25). The kinase that phosphorylates the hydrophobic function. OSR1 and STE20/SPS1-related proline-, alanine-rich kinase motif site under many circumstances is the mammalian target are activated by with no lysine [K] protein kinases that phosphory- of rapamycin complex 2 (mTORC2), which provides an addi- late the essential activation loop regulatory site on these kinases. tional phosphatidylinositol-3 kinase (PI3K)-dependent input to We found that inhibition of phosphoinositide 3-kinase (PI3K) these kinases (26–33). reduced OSR1 activation by osmotic stress. Inhibition of the PI3K In this study, we show that OSR1 is phosphorylated not only target pathway, the mammalian target of rapamycin complex 2 by WNKs but also on a C-terminal site, conserved in SPAK, by (mTORC2), by depletion of Sin1, one of its components, decreased mTORC2. These studies reveal a link between WNK-OSR1/SPAK activation of OSR1 by sorbitol and reduced activity of the OSR1 and the PI3K-mTORC2 cascade that suggests that OSR1 and substrate, the sodium, potassium, two chloride cotransporter, in SPAK integrate signals from osmosensing and survival pathways. HeLa cells. OSR1 activity was also reduced with a pharmacological inhibitor of mTOR. mTORC2 phosphorylated OSR1 on S339 in vitro, Results and mutation of this residue eliminated OSR1 phosphorylation by OSR1 Is Regulated by a PI3K-Dependent Mechanism. In response to mTORC2. Thus, we identify a previously unrecognized connection changes in tonicity, OSR1 is activated through phosphorylation of the PI3K pathway through mTORC2 to a Ste20 protein kinase and of its activation loop by WNKs. Previously, we failed to find ion homeostasis. activation of OSR1 by serum or epidermal growth factor (4). A recent report, however, indicates that it participates in insulin- phosphoregulation | Akt | ion transport | WNK1 regulated events in a PI3K-sensitive manner (34). To confirm the PI3K sensitivity and retest potential regulation by growth factors, he protein kinases oxidative stress-responsive 1 (OSR1) and we examined effects of the PI3K inhibitor wortmannin on OSR1 Tits homolog the STE20/SPS1-related proline-, alanine-rich activity in HeLa cells stimulated with sorbitol or serum. The kinase (SPAK or PASK) are the mammalian members of the sodium, potassium, two chloride cotransporters 1 and 2 (NKCC1 germ-cell kinase VI subgroup of the large Ste20 branch of the and NKCC2) are related ion cotransporters of the solute carrier mammalian kinome. OSR1 and SPAK directly regulate the sol- 12 family that are phosphorylated and activated by OSR1/SPAK ute carrier 12 family of cation-chloride cotransporters which (2, 15). The activity of immunoprecipitated OSR1 was measured modulate ion homeostasis throughout the body (1, 2). OSR1/ using a recombinant N-terminal fragment of NKCC2, residues – SPAK kinase domains lie close to their N-termini and they con- 1 175, as substrate (9). Sorbitol stimulated OSR1 activity, but A tain two additional conserved regions named “PF1” and “PF2” serum did not, consistent with earlier results (Fig. 1 ). Wortmannin [PASK and Fray (Drosophila homolog)] (3). PF1 is a C-terminal decreased serum-stimulated phosphorylation of Akt on its hydro- extension to the kinase domain and is required for enzyme ac- phobic motif site and also reduced sorbitol-stimulated OSR1 kinase tivity (4). PF2 binds the consensus motif [(R/K)FX(V/I)] (5) in substrates including ion cotransporters and in regulators. OSR1 Significance and SPAK are activated by with no lysine [K] (WNK) protein kinases, which phosphorylate the essential activation loop regu- With no lysine [K] (WNK) protein kinases are sensitive to latory site as well as a second site in the PF1 region with an un- changes in osmotic stress. Through the downstream protein defined function (6–9). kinases oxidative stress-responsive 1 (OSR1) and STE20/SPS1- The four WNK protein kinases are large enzymes notable for related proline-, alanine-rich kinase, WNKs regulate a family of the alternative placement of the essential ATP-binding lysine ion cotransporters and thereby modulate a range of processes residue in their catalytic domains, distinguishing them from other including cell volume homeostasis, blood pressure, hearing, members of the protein kinase superfamily (10, 11). Initial at- and kidney function. We found that a major phosphoinositide tention was focused on these enzymes because certain mutations 3-kinase target pathway, the mammalian target of rapamycin in two family members cause pseudohypoaldosteronism type II, a complex 2, also phosphorylates OSR1, coordinating with WNK1 heritable form of hypertension (12). WNKs are activated by to enhance OSR1 and ion cotransporter function. changes in tonicity. Cellular reconstitution studies and mouse genetics demonstrated the importance of WNK function in cell Author contributions: S. Sengupta, S.E., D.C.T., H.M., and M.H.C. designed research; – S. Sengupta, A.L.-R., S.E., S. Stippec, and X.G. performed research; X.G., D.C.T., and H.M. volume regulation and maintenance of blood pressure (13 19). contributed new reagents/analytic tools; S. Sengupta, A.L.-R., S.E., S. Stippec, D.C.T., and H.M. Control of cation-chloride cotransporters through OSR1 and analyzed data; and S. Sengupta, A.L.-R., and M.H.C. wrote the paper. SPAK is among the best-documented actions of WNKs in diverse The authors declare no conflict of interest. – tissues (5, 20 22). 1To whom correspondence should be addressed. E-mail: melanie.cobb@utsouthwestern. WNKs also regulate serum- and glucocorticoid-inducible pro- edu. tein kinases (SGKs) through a noncatalytic mechanism leading This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. to increased sodium influx through the epithelial sodium channel 1073/pnas.1318676110/-/DCSupplemental. 18826–18831 | PNAS | November 19, 2013 | vol. 110 | no. 47 www.pnas.org/cgi/doi/10.1073/pnas.1318676110 Downloaded by guest on September 28, 2021 A OSR1 Is Regulated by WNK1 and mTORC2. Because of the input of 5 *** mTORC2 to SGK (27), we tested the possibility that mTORC2 4 might be responsible for the PI3K-dependence of OSR1 acti- 3 vation by sorbitol. To evaluate the contribution of mTORC2, we inhibited its activity by depleting Sin1, a required component of 2 complex 2 (26). Knockdown of Sin1 reduced activation of OSR1 relative units 1 by sorbitol (Fig. 1B), supporting the conclusion that mTORC2 is OSR1 kinase activity, 0 a PI3K-dependent input to OSR1. In contrast to NKCC2 which Control Sorbitol FBS Wortmannin - + - + - + displays tissue-restricted expression in kidney, NKCC1 is expressed Kinase in most cell types including HeLa. To test the consequences of assay NKCC Sin1 depletion on cation-chloride cotransporter function, we OSR pAkt * A 120 B 5 ** 100 OSR 4 NKCC 80 3 60 relative units 2 40 OSR1 kinase activity, 1 Fold kinase activity 20 0 Sorbitol - - + + - - + + 0 siControl siSin1 Sorbitol - + + + Rapa KU Kinase assay Sin1 BIOCHEMISTRY OSR1 ERK1/2 NKCC Akt pAkt B C ** Rb uptake 86 WNK1 kinase activity, % WNK1 Fold bumetanide-sensitive Fold bumetanide-sensitive Kinase assay Fig. 1. PI3K pathways influence OSR1 activation and function in response to sorbitol. (A) HeLa cells were pretreated with 50 nM wortmannin (Wort) and GST-OSR1KR then stimulated with 0.5 M sorbitol or 20% FBS to stimulate Akt. Endogenous WNK1 OSR1 was immunoprecipitated and its activity measured using recombinant Sin1- NKCC2 1–175. Four such experiments were quantified (Top). A representative autoradiogram is shown with immunoblots of OSR1 and Akt phosphorylated on S473. Phosphorylation of Akt at S473 measured as an indicator of mTORC2 Fig. 2. Inhibition of mTORC2 reduces OSR1 activity. (A) HeLa cells were activity and pAkt as a positive control of stimulation conditions. n = 4, one pretreated for 15 min with either 100 nM rapamycin (Rapa) or 300 nM KU- way ANOVA, P < 0.0001; ***P = 0.0003 (adjusted from Tukey’s test). Error 0063794 (KU) and then stimulated with 0.5 M sorbitol (Sorb). Endogenous bars show standard deviation. (B) Effect of depletion of endogenous mTORC2 OSR1 was immunoprecipitated and its autophosphorylation and phosphor- by knockdown of Sin1 on OSR1 autophosphorylation (white bars) and activity ylation of recombinant NKCC2 1–175 were measured by immune-complex toward substrate (gray bars) upon sorbitol stimulation. n = 5, **P < 0.05. Error kinase assay. The incorporated radioactivity was measured by scintillation bars show standard error. Immunoblots show efficiency of Sin1 knockdown. counting and normalized to the amount of OSR1 immunoprecipitated in ERK1/2 was used as the loading control. Expression of Sin1 was normalized to each case. Cells stimulated with sorbitol without any drugs and without ERK1/2 expression (Bottom). (C) HeLa cells were transfected with siRNA for any other treatment were used as controls. Four experiments with 10 rep- Sin1 and scrambled siRNA as control (siC). Bumetanide sensitive uptake of licates were used to calculate standard error (error bars). *P < 0.05. Immu- 86Rb was measured as an assay of NKCC1 activity.
Load more

Recommended publications
  • FK506-Binding Protein 12.6/1B, a Negative Regulator of [Ca2+], Rescues Memory and Restores Genomic Regulation in the Hippocampus of Aging Rats
    This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. A link to any extended data will be provided when the final version is posted online. Research Articles: Neurobiology of Disease FK506-Binding Protein 12.6/1b, a negative regulator of [Ca2+], rescues memory and restores genomic regulation in the hippocampus of aging rats John C. Gant1, Eric M. Blalock1, Kuey-Chu Chen1, Inga Kadish2, Olivier Thibault1, Nada M. Porter1 and Philip W. Landfield1 1Department of Pharmacology & Nutritional Sciences, University of Kentucky, Lexington, KY 40536 2Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294 DOI: 10.1523/JNEUROSCI.2234-17.2017 Received: 7 August 2017 Revised: 10 October 2017 Accepted: 24 November 2017 Published: 18 December 2017 Author contributions: J.C.G. and P.W.L. designed research; J.C.G., E.M.B., K.-c.C., and I.K. performed research; J.C.G., E.M.B., K.-c.C., I.K., and P.W.L. analyzed data; J.C.G., E.M.B., O.T., N.M.P., and P.W.L. wrote the paper. Conflict of Interest: The authors declare no competing financial interests. NIH grants AG004542, AG033649, AG052050, AG037868 and McAlpine Foundation for Neuroscience Research Corresponding author: Philip W. Landfield, [email protected], Department of Pharmacology & Nutritional Sciences, University of Kentucky, 800 Rose Street, UKMC MS 307, Lexington, KY 40536 Cite as: J. Neurosci ; 10.1523/JNEUROSCI.2234-17.2017 Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formatted version of this article is published.
    [Show full text]
  • Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB
    Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent
    [Show full text]
  • ATP-Induced Focal Adhesion Kinase Activity Is Negatively Modulated by Phospholipase D2 in PC12 Cells
    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 33, No. 3, 150-155, September 2001 ATP-induced focal adhesion kinase activity is negatively modulated by phospholipase D2 in PC12 cells Yoe-Sik Bae1 and Sung Ho Ryu1,2 Introduction 1 Division of Molecular and Life Sciences, Pohang University of Purinergic receptors have been reported to play impor- Science and Technology, Pohang 790-784, Korea tant roles on the regulation of neuronal cell functions 2 Corresponding author: Tel, +82-54-279-2292; (Communi et al., 2000; Di Iorio et al., 1998). ATP, a Fax, +82-54-279-2199; E-mail, [email protected] ligand for the receptors modulate various cellular re- sponses such as mitogenic and morphogenic activity in Accepted 18 September 2001 PC12 rat pheochromocytoma cells (Neary et al., 1996; Soltoff et al., 1998; Schindelholz et al., 2000). Stimu- Abbreviations: Fak, focal adhesion kinase; PLD, phospholipase D; lation of cells with ATP induces tyrosine phosphorylation PA, phosphatidic acid; PC, phosphatidylcholine; DAG, diacylglyc- of several cytoskeletal proteins and focal adhesion erol; PBt, phosphatidylbutanol; PKC, protein kinase C; PAP, phos- molecules such as focal adhesion kinase (Fak), proline- phatidic acid phosphohydrolase rich tyrosine kinase (Pyk2), and paxillin (Soltoff et al., 1998; Schindelholz et al., 2000). Since these cytosk- eleton-associated proteins have been regarded as important factors for the regulation of neuronal cell Abstract functions, the study on the regulatory mechanism for the proteins remains an important issue. Extracellular ATP has been known to modulate vari- Phospholipase D (PLD) catalyzes the hydrolysis of ous cellular responses including mitogenesis, secre- phosphatidylcholine (PC) into phosphatidic acid (PA) tion and morphogenic activity in neuronal cells.
    [Show full text]
  • Download (Pdf)
    Invivoscribe's wholly-owned Laboratories for Personalized Molecular LabPMM LLC Medicine® (LabPMM) is a network of international reference laboratories that provide the medical and pharmaceutical communities with worldwide Located in San Diego, California, USA, it holds access to harmonized and standardized clinical testing services. We view the following accreditations and certifications: internationally reproducible and concordant testing as a requirement for ISO 15189, CAP, and CLIA, and is licensed to provide diagnostic consistent stratification of patients for enrollment in clinical trials, and the laboratory services in the states of California, Florida, foundation for establishing optimized treatment schedules linked to patient’s Maryland, New York, Pennsylvania, and Rhode Island. individual profile. LabPMM provides reliable patient stratification at diagnosis LabPMM GmbH and monitoring, throughout the entire course of treatment in support of Personalized Molecular Medicine® and Personalized Based in Martinsried (Munich), Germany. It is an ISO 15189 Molecular Diagnostics®. accredited international reference laboratory. CLIA/CAP accreditation is planned. Invivoscribe currently operates four clinical laboratories to serve partners in the USA (San Diego, CA), Europe (Munich, Germany), and Asia (Tokyo, Japan and Shanghai, China). These laboratories use the same critical LabPMM 合同会社 reagents and software which are developed consistently with ISO Located in Kawasaki (Tokyo), Japan and a licensed clinical lab. 13485 design control. Our cGMP reagents, rigorous standards for assay development & validation, and testing performed consistently under ISO 15189 requirements help ensure LabPMM generates standardized and concordant test results worldwide. Invivoscribe Diagnostic Technologies (Shanghai) Co., Ltd. LabPMM is an international network of PersonalMed Laboratories® focused on molecular oncology biomarker studies. Located in Shangai, China.
    [Show full text]
  • Datasheet for Protein Phosphatase 1 (PP1) (P0754; Lot 0121306)
    Supplied in: 200 mM NaCl, 50 mM HEPES Unit Definition: One unit is defined as Notes On Use: Avoid freeze/thaw cycles. Can be Protein the amount of enzyme that hydrolyzes 1 nmol of stored for 1 week or less at –20°C. (pH 7.0 @ 25°C), 1 mM MnCl2, 0.1 mM EGTA, Phosphatase 1 2.5 mM dithiothreitol, 0.025% Tween-20 and p-Nitrophenyl Phosphate (50 mM) (NEB #P0757) 50% glycerol. Store at –70°C in 1 minute at 30°C in a total reaction volume of The following information can be used as (PP1) 50 µl. suggested initial conditions for dephosphorylation 1-800-632-7799 Applications: PP1 can be used to release of proteins with PP1. [email protected] phosphate groups from phosphorylated serine, Specific Activity: ~ 80,000 units/mg. www.neb.com 0.1 unit of PP1 removes ~100% of phosphates P0754S 012130614061 threonine and tyrosine residues in proteins. Note that different proteins are dephosphorylated at Molecular Weight: 37.5 kDa. (0.5 nmol) from phosphoserine/threonine different rates. residues in phosphorylase a as well as in P0754S r y Purity: PP1 has been purified to > 90% phosphorylated myelin basic protein (phospho- 100 units 2,500 U/ml Lot: 0121306 Reagents Supplied with Enzyme: homogeneity as determined by SDS-PAGE and MyBP, 18.5 kDa) in 30 minutes in a 50 µl reaction. RECOMBINANT Store at –70°C Exp: 6/14 10X NEBuffer for Protein MetalloPhosphatases Coomassie Blue staining. The concentration of phospho-MyBP is 10 µM (PMP) with respect to phosphate. Description: Protein Phosphatase 1 (PP1) is a 10X MnCl2 (10 mM) Quality Assurance: PP1 contains no detectable Mn2+-dependent protein phosphatase with activity protease activity.
    [Show full text]
  • Ubiquitin Ligase Trim32 and Chloride-Sensitive WNK1 As Regulators of Potassium Channels in the Brain Eugene Miler Cilento University of Vermont
    University of Vermont ScholarWorks @ UVM Graduate College Dissertations and Theses Dissertations and Theses 2015 Ubiquitin Ligase Trim32 and Chloride-sensitive WNK1 as Regulators of Potassium Channels in the Brain Eugene Miler Cilento University of Vermont Follow this and additional works at: http://scholarworks.uvm.edu/graddis Part of the Neurosciences Commons, and the Pharmacology Commons Recommended Citation Cilento, Eugene Miler, "Ubiquitin Ligase Trim32 and Chloride-sensitive WNK1 as Regulators of Potassium Channels in the Brain" (2015). Graduate College Dissertations and Theses. Paper 431. This Dissertation is brought to you for free and open access by the Dissertations and Theses at ScholarWorks @ UVM. It has been accepted for inclusion in Graduate College Dissertations and Theses by an authorized administrator of ScholarWorks @ UVM. For more information, please contact [email protected]. UBIQUITIN LIGASE TRIM32 AND CHLORIDE-SENSITIVE WNK1 AS REGULATORS OF POTASSIUM CHANNELS IN THE BRAIN A Dissertation Presented by Eugene Miler Cilento to The Faculty of the Graduate College of The University of Vermont In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Specializing in Neuroscience October, 2015 Defense Date: August 04, 2014 Dissertation Examination Committee: Anthony Morielli, Ph.D., Advisor John Green, Ph.D., Chairperson Bryan Ballif, Ph.D. Wolfgang Dostmann Ph.D. George Wellman, Ph.D. Cynthia J. Forehand, Ph.D., Dean of the Graduate College ABSTRACT The voltage-gated potassium channel Kv1.2 impacts membrane potential and therefore excitability of neurons. Expression of Kv1.2 at the plasma membrane (PM) is critical for channel function, and altering Kv1.2 at the PM is one way to affect membrane excitability.
    [Show full text]
  • Supplementary Information Material and Methods
    MCT-11-0474 BKM120: a potent and specific pan-PI3K inhibitor Supplementary Information Material and methods Chemicals The EGFR inhibitor NVP-AEE788 (Novartis), the Jak inhibitor I (Merck Calbiochem, #420099) and anisomycin (Alomone labs, # A-520) were prepared as 50 mM stock solutions in 100% DMSO. Doxorubicin (Adriablastin, Pfizer), EGF (Sigma Ref: E9644), PDGF (Sigma, Ref: P4306) and IL-4 (Sigma, Ref: I-4269) stock solutions were prepared as recommended by the manufacturer. For in vivo administration: Temodal (20 mg Temozolomide capsules, Essex Chemie AG, Luzern) was dissolved in 4 mL KZI/glucose (20/80, vol/vol); Taxotere was bought as 40 mg/mL solution (Sanofi Aventis, France), and prepared in KZI/glucose. Antibodies The primary antibodies used were as follows: anti-S473P-Akt (#9271), anti-T308P-Akt (#9276,), anti-S9P-GSK3β (#9336), anti-T389P-p70S6K (#9205), anti-YP/TP-Erk1/2 (#9101), anti-YP/TP-p38 (#9215), anti-YP/TP-JNK1/2 (#9101), anti-Y751P-PDGFR (#3161), anti- p21Cip1/Waf1 (#2946), anti-p27Kip1 (#2552) and anti-Ser15-p53 (#9284) antibodies were from Cell Signaling Technologies; anti-Akt (#05-591), anti-T32P-FKHRL1 (#06-952) and anti- PDGFR (#06-495) antibodies were from Upstate; anti-IGF-1R (#SC-713) and anti-EGFR (#SC-03) antibodies were from Santa Cruz; anti-GSK3α/β (#44610), anti-Y641P-Stat6 (#611566), anti-S1981P-ATM (#200-301), anti-T2609 DNA-PKcs (#GTX24194) and anti- 1 MCT-11-0474 BKM120: a potent and specific pan-PI3K inhibitor Y1316P-IGF-1R were from Bio-Source International, Becton-Dickinson, Rockland, GenTex and internal production, respectively. The 4G10 antibody was from Millipore (#05-321MG).
    [Show full text]
  • Role of Phospholipases in Adrenal Steroidogenesis
    229 1 W B BOLLAG Phospholipases in adrenal 229:1 R29–R41 Review steroidogenesis Role of phospholipases in adrenal steroidogenesis Wendy B Bollag Correspondence should be addressed Charlie Norwood VA Medical Center, One Freedom Way, Augusta, GA, USA to W B Bollag Department of Physiology, Medical College of Georgia, Augusta University (formerly Georgia Regents Email University), Augusta, GA, USA [email protected] Abstract Phospholipases are lipid-metabolizing enzymes that hydrolyze phospholipids. In some Key Words cases, their activity results in remodeling of lipids and/or allows the synthesis of other f adrenal cortex lipids. In other cases, however, and of interest to the topic of adrenal steroidogenesis, f angiotensin phospholipases produce second messengers that modify the function of a cell. In this f intracellular signaling review, the enzymatic reactions, products, and effectors of three phospholipases, f phospholipids phospholipase C, phospholipase D, and phospholipase A2, are discussed. Although f signal transduction much data have been obtained concerning the role of phospholipases C and D in regulating adrenal steroid hormone production, there are still many gaps in our knowledge. Furthermore, little is known about the involvement of phospholipase A2, Endocrinology perhaps, in part, because this enzyme comprises a large family of related enzymes of that are differentially regulated and with different functions. This review presents the evidence supporting the role of each of these phospholipases in steroidogenesis in the Journal Journal of Endocrinology adrenal cortex. (2016) 229, R1–R13 Introduction associated GTP-binding protein exchanges a bound GDP for a GTP. The G protein with GTP bound can then Phospholipids serve a structural function in the cell in that activate the enzyme, phospholipase C (PLC), that cleaves they form the lipid bilayer that maintains cell integrity.
    [Show full text]
  • Effects of Rapamycin on Social Interaction Deficits and Gene
    Kotajima-Murakami et al. Molecular Brain (2019) 12:3 https://doi.org/10.1186/s13041-018-0423-2 RESEARCH Open Access Effects of rapamycin on social interaction deficits and gene expression in mice exposed to valproic acid in utero Hiroko Kotajima-Murakami1,2, Toshiyuki Kobayashi3, Hirofumi Kashii1,4, Atsushi Sato1,5, Yoko Hagino1, Miho Tanaka1,6, Yasumasa Nishito7, Yukio Takamatsu7, Shigeo Uchino1,2 and Kazutaka Ikeda1* Abstract The mammalian target of rapamycin (mTOR) signaling pathway plays a crucial role in cell metabolism, growth, and proliferation. The overactivation of mTOR has been implicated in the pathogenesis of syndromic autism spectrum disorder (ASD), such as tuberous sclerosis complex (TSC). Treatment with the mTOR inhibitor rapamycin improved social interaction deficits in mouse models of TSC. Prenatal exposure to valproic acid (VPA) increases the incidence of ASD. Rodent pups that are exposed to VPA in utero have been used as an animal model of ASD. Activation of the mTOR signaling pathway was recently observed in rodents that were exposed to VPA in utero, and rapamycin ameliorated social interaction deficits. The present study investigated the effect of rapamycin on social interaction deficits in both adolescence and adulthood, and gene expressions in mice that were exposed to VPA in utero. We subcutaneously injected 600 mg/kg VPA in pregnant mice on gestational day 12.5 and used the pups as a model of ASD. The pups were intraperitoneally injected with rapamycin or an equal volume of vehicle once daily for 2 consecutive days. The social interaction test was conducted in the offspring after the last rapamycin administration at 5–6 weeks of ages (adolescence) or 10–11 weeks of age (adulthood).
    [Show full text]
  • Multistep Regulation of Autophagy by WNK1
    Multistep regulation of autophagy by WNK1 Sachith Gallolu Kankanamalagea, A-Young Leea, Chonlarat Wichaidita, Andres Lorente-Rodrigueza, Akansha M. Shaha, Steve Stippeca, Angelique W. Whitehurstb, and Melanie H. Cobba,b,1 aDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390; and bHarold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390 Contributed by Melanie H. Cobb, October 27, 2016 (sent for review September 6, 2016; reviewed by Jing Liu and Helen Piwnica-Worms) The with-no-lysine (K) (WNK) kinases are an atypical family of components and to supply cells with nutrients and building blocks protein kinases that regulate ion transport across cell membranes. (30–33). Autophagy is induced by cellular stress and protects Mutations that result in their overexpression cause hypertension- against infections by pathogens (34–40). Critical to maintain in- related disorders in humans. Of the four mammalian WNKs, only tracellular homeostasis, autophagy has roles in diseases, such as WNK1 is expressed throughout the body. We report that WNK1 neurodegeneration (41, 42) and cancer (43, 44). In this study, we inhibits autophagy, an intracellular degradation pathway impli- show that WNK1 is involved in regulating autophagy. cated in several human diseases. Using small-interfering RNA- mediated WNK1 knockdown, we show autophagosome formation Results and autophagic flux are accelerated. In cells with reduced WNK1, WNK1 Depletion Increases Autophagy. To analyze its role in auto- basal and starvation-induced autophagy is increased. We also phagy, WNK1 was knocked down with small interfering RNA show that depletion of WNK1 stimulates focal class III phospha- (siRNA) in U2OS cells stably expressing green fluorescent protein- tidylinositol 3-kinase complex (PI3KC3) activity, which is required tagged light chain 3 (GFP-LC3) (32, 45).
    [Show full text]
  • Src-Family Kinases Impact Prognosis and Targeted Therapy in Flt3-ITD+ Acute Myeloid Leukemia
    Src-Family Kinases Impact Prognosis and Targeted Therapy in Flt3-ITD+ Acute Myeloid Leukemia Title Page by Ravi K. Patel Bachelor of Science, University of Minnesota, 2013 Submitted to the Graduate Faculty of School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2019 Commi ttee Membership Pa UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE Commi ttee Membership Page This dissertation was presented by Ravi K. Patel It was defended on May 31, 2019 and approved by Qiming (Jane) Wang, Associate Professor Pharmacology and Chemical Biology Vaughn S. Cooper, Professor of Microbiology and Molecular Genetics Adrian Lee, Professor of Pharmacology and Chemical Biology Laura Stabile, Research Associate Professor of Pharmacology and Chemical Biology Thomas E. Smithgall, Dissertation Director, Professor and Chair of Microbiology and Molecular Genetics ii Copyright © by Ravi K. Patel 2019 iii Abstract Src-Family Kinases Play an Important Role in Flt3-ITD Acute Myeloid Leukemia Prognosis and Drug Efficacy Ravi K. Patel, PhD University of Pittsburgh, 2019 Abstract Acute myelogenous leukemia (AML) is a disease characterized by undifferentiated bone-marrow progenitor cells dominating the bone marrow. Currently the five-year survival rate for AML patients is 27.4 percent. Meanwhile the standard of care for most AML patients has not changed for nearly 50 years. We now know that AML is a genetically heterogeneous disease and therefore it is unlikely that all AML patients will respond to therapy the same way. Upregulation of protein-tyrosine kinase signaling pathways is one common feature of some AML tumors, offering opportunities for targeted therapy.
    [Show full text]
  • Accession Description Biological Process Cellular Component P-Value SCZ/CTRL Ration A4FU69 EF-Hand Calcium-Binding Domain-Contai
    Accession Description Biological Process Cellular component p-Value SCZ/CTRL ration A4FU69 EF-hand calcium-binding domain-containing protein 5 0,001101 2,724427411 A4UGR9 Xin actin-binding repeat-containing protein 2 Cytoskeletal anchoring Cytoplasm 0,006756 1,413953388 A6NCE7 Microtubule-associated proteins 1A/1B light chain 3 beta 2 Cytoplasm 0,001417 1,99612969 B2RPK0 Putative high mobility group protein B1-like 1 0,032314 1,590743352 O00231 26S proteasome non-ATPase regulatory subunit 11 Protein metabolism Cytoplasm; Nucleus 0,000029 1,428664042 O00232 26S proteasome non-ATPase regulatory subunit 12 Protein metabolism Cytoplasm 0,008566 1,544545922 O00264 Membrane-associated progesterone receptor component 1 Cell communication Plasma membrane 0,001459 2,322924147 O00429 Dynamin-1-like protein Mitochondrion organization and biogenesis Cytoplasm 0,006560 0,06391487 O00567 Nucleolar protein 56 Regulation of nucleotide metabolism Nucleus 0,007330 3,842896338 O14737 Programmed cell death protein 5 Apoptosis Cytoplasm; Nucleus 0,006358 3,836727237 O14818 Proteasome subunit alpha type-7 Protein metabolism Cytoplasm 0,030521 1,893928387 O14979 Heterogeneous nuclear ribonucleoprotein D-like Regulation of nucleotide metabolism Nucleus 0,000637 2,150005885 O15078 Centrosomal protein of 290 kDa 0,015359 14,26648619 O15347 High mobility group protein B3 Regulation of nucleotide metabolism Nucleus 0,005500 1,364309014 O15540 Fatty acid-binding protein_ brain Transport Cytoplasm 0,000087 3,125786118 O43237 Cytoplasmic dynein 1 light intermediate
    [Show full text]